REFERENCES
1. Yang L, Yang Y, Huang L, Cui X, Liu Y. From single- to multi-omics: future research trends in medicinal plants. Brief Bioinform. 2023;24:bbac485.
2. M S, Puthiyedath R, Pillai ZS. Drug-herb interactions: a challenge and clinical concern in primary healthcare. Front Med. 2025;12:1657005.
3. Zhou W, Liu H, Qiu LZ, et al. Cardiac efficacy and toxicity of aconitine: a new frontier for the ancient poison. Med Res Rev. 2021;41:1798-811.
4. Ren Y, Qu S. Constituent isoflavones of Puerariae radix as a potential neuroprotector in cognitive impairment: evidence from preclinical studies. Ageing Res Rev. 2023;90:102040.
5. Zhang H, Xiong J, Wang Q, et al. Chrysophanol delays aging via insulin/IGF-1 signaling pathway. Free Radic Biol Med. 2025;232:269-78.
6. Yang HS, Mauki DH, Zheng YX, Wang TH, He XY. Terpenoids: a promising traditional chinese medicine for neuropathic pain relief. Pharmacol Res. 2025;216:107789.
7. Chai M, Gao B, Wang S, et al. Leveraging plant-derived nanovesicles for advanced nucleic acid-based gene therapy. Theranostics. 2025;15:324-39.
8. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806-11.
9. Zhang L, Hou D, Chen X, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res. 2012;22:107-26.
10. Huang F, Du J, Liang Z, et al. Large-scale analysis of small RNAs derived from traditional Chinese herbs in human tissues. Sci China Life Sci. 2019;62:321-32.
11. Shi R, Tan W, Jin H, et al. MicroRNA-enriched plant-derived exosomes alleviate colitis by modulating systemic immunity, metabolic homeostasis, and gut microbiota. Adv Sci. 2025;12:e05921.
12. Liu J, Wang F, Song H, et al. Soybean-derived gma-miR159a alleviates colon tumorigenesis by suppressing TCF7/MYC in mice. J Nutr Biochem. 2021;92:108627.
13. Zhou LK, Zhou Z, Jiang XM, et al. Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients. Cell Discov. 2020;6:54.
14. Binder AK, Bremm F, Dörrie J, Schaft N. Non-coding RNA in tumor cells and tumor-associated myeloid cells-function and therapeutic potential. Int J Mol Sci. 2024;25:7275.
15. Zhan J, Meyers BC. Plant small RNAs: their biogenesis, regulatory roles, and functions. Annu Rev Plant Biol. 2023;74:21-51.
16. Yang HH, Zheng BL. Biogenesis, action, function of plant small RNAs and their potential application in agriculture. Yi Chuan. 2025;47:928-43.
17. Tang Q, Khvorova A. RNAi-based drug design: considerations and future directions. Nat Rev Drug Discov. 2024;23:341-64.
18. Zhang Z, Yu M, Hu G, Gan Y. The new era of siRNA therapy: advances in cancer treatment. Clin Transl Med. 2025;15:e70363.
19. Ajila V, Colley L, Ste-Croix DT, et al. P-TarPmiR accurately predicts plant-specific miRNA targets. Sci Rep. 2023;13:332.
20. Yang L, Feng H. Cross-kingdom regulation by plant-derived miRNAs in mammalian systems. Animal Model Exp Med. 2023;6:518-25.
21. Diener C, Keller A, Meese E. The miRNA-target interactions: an underestimated intricacy. Nucleic Acids Res. 2024;52:1544-57.
22. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20.
23. Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA. 2004;10:1813-9.
24. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843-54.
25. Yang Y, Chen X, Chen J, Xu H, Li J, Zhang Z. Differential miRNA expression in Rehmannia glutinosa plants subjected to continuous cropping. BMC Plant Biol. 2011;11:53.
26. Xu T, Wang B, Liu X, Feng R, Dong M, Chen J. Microarray-based identification of conserved microRNAs from Pinellia ternata. Gene. 2012;493:267-72.
27. Dong M, Yang D, Lang Q, Zhou W, Xu S, Xu T. Microarray and degradome sequencing reveal microRNA differential expression profiles and their targets in Pinellia pedatisecta. PLoS One. 2013;8:e75978.
28. Fan R, Li Y, Li C, Zhang Y. Differential microRNA analysis of glandular trichomes and young leaves in Xanthium strumarium L. reveals their putative roles in regulating terpenoid biosynthesis. PLoS One. 2015;10:e0139002.
29. Wei R, Qiu D, Wilson IW, et al. Identification of novel and conserved microRNAs in Panax notoginseng roots by high-throughput sequencing. BMC Genomics. 2015;16:835.
30. Gao ZH, Wei JH, Yang Y, Zhang Z, Xiong HY, Zhao WT. Identification of conserved and novel microRNAs in Aquilaria sinensis based on small RNA sequencing and transcriptome sequence data. Gene. 2012;505:167-75.
31. Jung I, Kang H, Kim JU, Chang H, Kim S, Jung W. The mRNA and miRNA transcriptomic landscape of Panax ginseng under the high ambient temperature. BMC Syst Biol. 2018;12:27.
32. Gu L, Lai Y, Zhang G, et al. Genome-wide identification of the Rehmannia glutinosa miRNA family and exploration of their expression characteristics caused by the replant disease formation-related principal factor. Genes. 2024;15:1239.
33. He X, Shenkute AG, Wang W, Xu S. Characterization of conserved and novel microRNAs in Lilium lancifolium Thunb. by high-throughput sequencing. Sci Rep. 2018;8:2880.
34. Nadiya F, Anjali N, Thomas J, Gangaprasad A, Sabu KK. Deep sequencing identified potential miRNAs involved in defence response, stress and plant growth characteristics of wild genotypes of cardamom. Plant Biol. 2019;21:3-14.
35. Boke H, Ozhuner E, Turktas M, Parmaksiz I, Ozcan S, Unver T. Regulation of the alkaloid biosynthesis by miRNA in opium poppy. Plant Biotechnol J. 2015;13:409-20.
36. Hao DC, Yang L, Xiao PG, Liu M. Identification of Taxus microRNAs and their targets with high-throughput sequencing and degradome analysis. Physiol Plant. 2012;146:388-403.
37. Shao J, Wang L, Liu Y, et al. Identification of milRNAs and their target genes in Ganoderma lucidum by high-throughput sequencing and degradome analysis. Fungal Genet Biol. 2020;136:103313.
38. Wang Y, Chen Y, Peng M, et al. Identification of microRNA and analysis of target genes in Panax ginseng. Chin Herb Med. 2023;15:69-75.
39. Zhou H, Jiang M, Li J, Xu Y, Li C, Lu S. Genome-wide identification and functional analysis of Salvia miltiorrhiza microRNAs reveal the negative regulatory role of Smi-miR159a in phenolic acid biosynthesis. Int J Mol Sci. 2024;25:5148.
40. Xia H, Zhang L, Wu G, et al. Genome-wide identification and characterization of microRNAs and target genes in lonicera japonica. PLoS One. 2016;11:e0164140.
41. Sasi S, Krishnan S, Kodackattumannil P, et al. DNA-free high-quality RNA extraction from 39 difficult-to-extract plant species (representing seasonal tissues and tissue types) of 32 families, and its validation for downstream molecular applications. Plant Methods. 2023;19:84.
42. Brown GN. Changes in ribonucleic acid fractions during maturation of mimosa epicotyl tissues. Plant Physiol. 1969;44:272-6.
43. Cho Y, Fernandes J, Kim SH, Walbot V. Gene-expression profile comparisons distinguish seven organs of maize. Genome Biol. 2002;3:research0045.
44. Bélanger S, Zhan J, Yu Y, Meyers BC. Comparative RNA profiling identifies stage-specific phasiRNAs and coexpressed Argonaute genes in Bambusoideae and Pooideae species. Plant Cell. 2024;37:koae308.
45. Kaushik N, Noorani MS, Shukla K, et al. CTAB protocol for obtaining high-quality total RNA from Hibiscus rosa-sinensis and other related plants of the family malvaceae. ACS Omega. 2024;9:20359-67.
46. Peng J, Xia Z, Chen L, et al. Rapid and efficient isolation of high-quality small RNAs from recalcitrant plant species rich in polyphenols and polysaccharides. PLoS One. 2014;9:e95687.
47. Yang BH, Liu BS, Chen ZL. DNA extraction with TRIzol reagent using a silica column. Anal Sci. 2021;37:1033-7.
48. Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Purification of RNA by SDS solubilization and phenol extraction. Cold Spring Harb Protoc. 2010;2010:pdb.prot5438.
49. Vennapusa AR, Somayanda IM, Doherty CJ, Jagadish SVK. A universal method for high-quality RNA extraction from plant tissues rich in starch, proteins and fiber. Sci Rep. 2020;10:16887.
50. Wang L, Stegemann JP. Extraction of high quality RNA from polysaccharide matrices using cetyltrimethylammonium bromide. Biomaterials. 2010;31:1612-8.
51. Yang Z, He CL, Li FF, et al. Optimization of conditions for total RNA extraction from green banana pulp using a modified hot borate method. Jiangsu Agric Sci. 2017;45:49-53. (in Chinese).
52. Pei Y, Mamtimin T, Ji J, et al. The guanidine thiocyanate-high EDTA method for total microbial RNA extraction from severely heavy metal-contaminated soils. Microb Biotechnol. 2021;14:465-78.
53. Baelde JJ, Bergijk EC, Hoedemaeker PJ, de Heer E, Bruijn JA. Optimal method for RNA extraction from mouse glomeruli. Nephrol Dial Transplant. 1994;9:304-8.
54. Shi R, Lewis RS, Panthee DR. Filter paper-based spin column method for cost-efficient DNA or RNA purification. PLoS One. 2018;13:e0203011.
55. Wang Y, Peng M, Wang W, et al. Verification of miRNAs in ginseng decoction by high-throughput sequencing and quantitative real-time PCR. Heliyon. 2019;5:e01418.
56. Luo Y, Wang P, Wang X, et al. Detection of dietetically absorbed maize-derived microRNAs in pigs. Sci Rep. 2017;7:645.
57. Xie W, Melzig MF. The stability of medicinal plant microRNAs in the herb preparation process. Molecules. 2018;23:919.
58. Wang X, Ren X, Ning L, Wang P, Xu K. Stability and absorption mechanism of typical plant miRNAs in an in vitro gastrointestinal environment: Basis for their cross-kingdom nutritional effects. J Nutr Biochem. 2020;81:108376.
59. Díez-Sainz E, Milagro FI, Aranaz P, Riezu-Boj JI, Lorente-Cebrián S. MicroRNAs from edible plants reach the human gastrointestinal tract and may act as potential regulators of gene expression. J Physiol Biochem. 2024;80:655-70.
60. Zhou Z, Li X, Liu J, et al. Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses. Cell Res. 2015;25:39-49.
61. Cavallini A, Minervini F, Garbetta A, et al. High degradation and no bioavailability of artichoke miRNAs assessed using an in vitro digestion/Caco-2 cell model. Nutr Res. 2018;60:68-76.
62. Qin X, Wang X, Xu K, et al. Digestion of plant dietary miRNAs starts in the mouth under the protection of coingested food components and plant-derived exosome-like nanoparticles. J Agric Food Chem. 2022;70:4316-27.
63. Del Pozo-Acebo L, López de Las Hazas MC, Margollés A, Dávalos A, García-Ruiz A. Eating microRNAs: pharmacological opportunities for cross-kingdom regulation and implications in host gene and gut microbiota modulation. Br J Pharmacol. 2021;178:2218-45.
64. Li J, Yang Z, Yu B, Liu J, Chen X. Methylation protects miRNAs and siRNAs from a 3’-end uridylation activity in Arabidopsis. Curr Biol. 2005;15:1501-7.
65. Xu Q, Wang J, Zhang Y, et al. Atypical plant miRNA cal-miR2911: robust stability against food digestion and specific promoting effect on Bifidobacterium in mice. J Agric Food Chem. 2024;72:4801-13.
66. Philip A, Ferro VA, Tate RJ. Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process. Mol Nutr Food Res. 2015;59:1962-72.
67. Chen Q, Zhang F, Dong L, et al. SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs. Cell Res. 2021;31:247-58.
68. Sun CR, Xu D, Yang F, et al. Human SIDT1 mediates dsRNA uptake via its phospholipase activity. Cell Res. 2024;34:84-7.
69. Zhao Y, Mo B, Chen X. Mechanisms that impact microRNA stability in plants. RNA Biol. 2012;9:1218-23.
70. Umezu T, Takanashi M, Murakami Y, et al. Acerola exosome-like nanovesicles to systemically deliver nucleic acid medicine via oral administration. Mol Ther Methods Clin Dev. 2021;21:199-208.
71. Tembo KM, Wang X, Bolideei M, et al. Exploring the bioactivity of microRNAs originated from plant-derived exosome-like nanoparticles (PELNs): current perspectives. J Nanobiotechnology. 2025;23:563.
72. Avsar B, Zhao Y, Li W, Lukiw WJ. Atropa belladonna expresses a microRNA (aba-miRNA-9497) highly homologous to Homo sapiens miRNA-378 (hsa-miRNA-378); both miRNAs target the 3’-Untranslated Region (3’-UTR) of the mRNA encoding the neurologically relevant, zinc-finger transcription factor ZNF-691. Cell Mol Neurobiol. 2020;40:179-88.
75. Yang GS, Zheng B, Qin Y, et al. Salvia miltiorrhiza-derived miRNAs suppress vascular remodeling through regulating OTUD7B/KLF4/NMHC IIA axis. Theranostics. 2020;10:7787-811.
76. Lv Q, Yang H, Xie Y, et al. Prunus mume derived extracellular vesicle-like particles alleviate experimental colitis via disrupting NEK7-NLRP3 interaction and inflammasome activation. J Nanobiotechnology. 2025;23:532.
77. Lei X, Li H, Chen S, et al. Tea leaf exosome-like nanoparticles (TELNs) improve oleic acid-induced lipid metabolism by regulating miRNAs in HepG-2 cells. Bioresour Bioprocess. 2025;12:9.
78. Meng X, Jin W, Wu F. Novel tomato miRNA miR1001 initiates cross-species regulation to suppress the conidiospore germination and infection virulence of Botrytis cinerea in vitro. Gene. 2020;759:145002.
79. Yan L, Cao Y, Hou L, et al. Ginger exosome-like nanoparticle-derived miRNA therapeutics: a strategic inhibitor of intestinal inflammation. J Adv Res. 2025;69:1-15.
80. Du J, Liang Z, Xu J, et al. Plant-derived phosphocholine facilitates cellular uptake of anti-pulmonary fibrotic HJT-sRNA-m7. Sci China Life Sci. 2019;62:309-20.
81. Qiu FS, Wang JF, Guo MY, et al. Rgl-exomiR-7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis. Biomed Pharmacother. 2023;165:115007.
82. Masood M, Everett CP, Chan SY, Snow JW. Negligible uptake and transfer of diet-derived pollen microRNAs in adult honey bees. RNA Biol. 2016;13:109-18.
83. Shi L, Guo C, Fang M, Yang Y, Yin F, Shen Y. Cross-kingdom regulation of plant microRNAs: potential application in crop improvement and human disease therapeutics. Front Plant Sci. 2024;15:1512047.
84. Miao Y, Fu C, Yu Z, et al. Current status and trends in small nucleic acid drug development: leading the future. Acta Pharm Sin B. 2024;14:3802-17.
85. van der Ree MH, van der Meer AJ, de Bruijne J, et al. Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antiviral Res. 2014;111:53-9.
86. van Zandwijk N, Pavlakis N, Kao SC, et al. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. Lancet Oncol. 2017;18:1386-96.
87. Hong DS, Kang YK, Borad M, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122:1630-7.
88. Gale DP, Gross O, Wang F, et al. ; HERA Clinical Trial Group. A randomized controlled clinical trial testing effects of lademirsen on kidney function decline in adults with alport syndrome. Clin J Am Soc Nephrol. 2024;19:995-1004.
89. Seto AG, Beatty X, Lynch JM, et al. Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma. Br J Haematol. 2018;183:428-44.
90. Farag M, Tabrizi SJ, Wild EJ. Huntington’s disease clinical trials update: March 2025. J Huntingtons Dis. 2025;14:191-206.
91. Abplanalp WT, Fischer A, John D, et al. Efficiency and target derepression of anti-miR-92a: results of a first in human study. Nucleic Acid Ther. 2020;30:335-45.
92. Owen T, Cole I, Drygin D, et al. Pharmacokinetics, safety, and tolerability of anti-miR-17 oligonucleotide RGLS4326 in healthy adult subjects. J Clin Pharmacol. 2026;66:e70207.
93. Täubel J, Hauke W, Rump S, et al. Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J. 2021;42:178-88.
94. Di Martino MT, Tagliaferri P, Tassone P. MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications. J Exp Clin Cancer Res. 2025;44:126.
95. Wang Z, Peng Y, Zhou H, Zhang M, Ju D, Chen Z. MiRNA-based drugs: challenges and delivery strategies. Appl Microbiol Biotechnol. 2025;109:247.
96. Sharma P, Kumar A, Agarwal T, et al. Nucleic acid-based therapeutics for dermal wound healing. Int J Biol Macromol. 2022;220:920-33.
97. Zare M, Pemmada R, Madhavan M, et al. Encapsulation of miRNA and siRNA into nanomaterials for cancer therapeutics. Pharmaceutics. 2022;14:1620.
98. Pagoni M, Cava C, Sideris DC, et al. miRNA-based technologies in cancer therapy. J Pers Med. 2023;13:1586.
99. Traber GM, Yu AM. RNAi-based therapeutics and novel RNA bioengineering technologies. J Pharmacol Exp Ther. 2023;384:133-54.
100. Asakiya C, Zhu L, Yuhan J, Zhu L, Huang K, Xu W. Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications. Expert Opin Drug Deliv. 2022;19:435-50.
101. Manikkath J, Jishnu PV, Wich PR, Manikkath A, Radhakrishnan R. Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine. 2022;17:181-95.
102. Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Control Release. 2013;172:962-74.
104. Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 2022;38:613-26.
105. Sainz V, Conniot J, Matos AI, et al. Regulatory aspects on nanomedicines. Biochem Biophys Res Commun. 2015;468:504-10.
106. Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N. MicroRNA therapeutics in cancer: current advances and challenges. Cancers. 2021;13:2680.
